|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008.
|
|
2
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005.
|
|
3
|
Jakola AS, Myrmel KS, Kloster R, et al:
Comparison of a strategy favoring early surgical resection vs a
strategy favoring watchful waiting in low-grade gliomas. JAMA.
308:1881–1888. 2012.
|
|
4
|
Reuss D and von Deimling A: Hereditary
tumor syndromes and gliomas. Recent Results Cancer Res. 171:83–102.
2009.
|
|
5
|
Moore SC, Rajaraman P, Dubrow R, et al:
Height, body mass index, and physical activity in relation to
glioma risk. Cancer Res. 69:8349–8355. 2009.
|
|
6
|
Kostron H, Swartz MR, Miller DC and
Martuza RL: The interaction of hematoporphyrin derivative, light,
and ionizing radiation in a rat glioma model. Cancer. 57:964–970.
1986.
|
|
7
|
Hocking B: Occupational exposure to
ionizing and non-ionizing radiation and risk of glioma. Occup Med
(Lond). 58:148–149. 2008.
|
|
8
|
Ron E, Modan B, Boice JD Jr, et al: Tumors
of the brain and nervous system after radiotherapy in childhood. N
Engl J Med. 319:1033–1039. 1988.
|
|
9
|
Shete S, Hosking FJ, Robertson LB, et al:
Genome-wide association study identifies five susceptibility loci
for glioma. Nat Genet. 41:899–904. 2009.
|
|
10
|
Wrensch M, Jenkins RB, Chang JS, et al:
Variants in the CDKN2B and RTEL1 regions are associated with
high-grade glioma susceptibility. Nat Genet. 41:905–908. 2009.
|
|
11
|
Griffin CS, Simpson PJ, Wilson CR and
Thacker J: Mammalian recombination-repair genes XRCC2 and XRCC3
promote correct chromosome segregation. Nat Cell Biol. 2:757–761.
2000.
|
|
12
|
Shen MR, Jones IM and Mohrenweiser H:
Nonconservative amino acid substitution variants exist at
polymorphic frequency in DNA repair genes in healthy humans. Cancer
Res. 58:604–608. 1998.
|
|
13
|
Zhao Y, Deng X, Wang Z, Wang Q and Liu Y:
Genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 and risk
of colorectal cancer in Chinese population. Asian Pac J Cancer
Prev. 13:665–669. 2012.
|
|
14
|
Cheng CX, Xue M, Li K and Li WS:
Predictive value of XRCC1 and XRCC3 gene polymorphisms for risk of
ovarian cancer death after chemotherapy. Asian Pac J Cancer Prev.
13:2541–2545. 2012.
|
|
15
|
Shaker OG and Sadik NA: Polymorphisms in
interleukin-10 and interleukin-28B genes in Egyptian patients with
chronic hepatitis C virus genotype 4 and their effect on the
response to pegylated interferon/ribavirin-therapy. J Gastroenterol
Hepatol. 27:1842–1849. 2012.
|
|
16
|
Yin QH, Liu C, Li L, Zu XY and Wang YJ:
Association between the XRCC3 T241M polymorphism and head and neck
cancer susceptibility: a meta-analysis of case-control studies.
Asian Pac J Cancer Prev. 13:5201–5205. 2012.
|
|
17
|
Zhu X, Zhong Z, Zhang X, et al: DNA repair
gene XRCC3 T241M polymorphism and bladder cancer risk in a Chinese
population. Genet Test Mol Biomarkers. 16:640–643. 2012.
|
|
18
|
Zhao P, Zou P, Zhao L, et al: Genetic
polymorphisms of DNA double-strand break repair pathway genes and
glioma susceptibility. BMC Cancer. 13:2342013.
|
|
19
|
Pan WR, Li G and Guan JH: Polymorphisms in
DNA repair genes and susceptibility to glioma in a chinese
population. Int J Mol Sci. 14:3314–3324. 2013.
|
|
20
|
Luo KQ, Mu SQ, Wu ZX, Shi YN and Peng JC:
Polymorphisms in DNA repair genes and risk of glioma and
meningioma. Asian Pac J Cancer Prev. 14:449–452. 2013.
|
|
21
|
Kiuru A, Lindholm C, Heinävaara S, et al:
XRCC1 and XRCC3 variants and risk of glioma and meningioma. J
Neurooncol. 88:135–142. 2008.
|
|
22
|
Wang LE, Bondy ML, Shen H, et al:
Polymorphisms of DNA repair genes and risk of glioma. Cancer Res.
64:5560–5563. 2004.
|
|
23
|
Zhao B, Ye J, Li B, Ma Q, Su G and Han R:
DNA repair gene XRCC3 Thr241Met polymorphism and glioma risk: a
meta-analysis. Int J Clin Exp Med. 6:438–443. 2013.
|
|
24
|
Jiang J, Quan XF, Zhang L and Wang YC: The
XRCC3 Thr241Met polymorphism influences glioma risk - a
meta-analysis. Asian Pac J Cancer Prev. 14:3169–3173. 2013.
|
|
25
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, et al: The 2007 WHO classification of tumours of the
central nervous system. Acta Neuropathol. 114:97–109. 2007.
|
|
26
|
Duan Z, Shen H, Lee JE, et al: DNA repair
gene XRCC3 241Met variant is not associated with risk of cutaneous
malignant melanoma. Cancer Epidemiol Biomarkers Prev. 11:1142–1143.
2002.
|
|
27
|
Fan Z, Wu Y, Shen J and Zhan R:
Glutathione S-transferase M1, T1, and P1 polymorphisms and risk of
glioma: a meta-analysis. Mol Biol Rep. 40:1641–1650. 2013.
|
|
28
|
Jacobs DI and Bracken MB: Association
between XRCC1 polymorphism 399 G→A and glioma among Caucasians: a
systematic review and meta-analysis. BMC Med Genet. 13:972012.
|
|
29
|
Sun JY, Zhang CY, Zhang ZJ, et al:
Association between XRCC1 gene polymorphisms and risk of glioma
development: a meta-analysis. Asian Pac J Cancer Prev.
13:4783–4788. 2012.
|
|
30
|
Wei X, Chen D and Lv T: A functional
polymorphism in XRCC1 is associated with glioma risk: evidence from
a meta-analysis. Mol Biol Rep. 40:567–572. 2013.
|
|
31
|
Fan W, Li S, Chen Q, Huang Z, Ma Q and
Xiao Z: Association between interleukin-10 promoter polymorphisms
and endometriosis: a meta-analysis. Gene. 515:49–55. 2013.
|
|
32
|
Zhan P, Wang Q, Qian Q and Yu LK: XRCC3
Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis.
J Exp Clin Cancer Res. 32:12013.
|
|
33
|
Wang Z and Zhang W: Association between
XRCC3 Thr241Met polymorphism and colorectal cancer risk. Tumour
Biol. 34:1421–1429. 2013.
|
|
34
|
Zhu H, Lei X, Liu Q and Wang Y:
Interleukin-10-1082A/G polymorphism and inflammatory bowel disease
susceptibility: a meta-analysis based on 17,585 subjects. Cytokine.
61:146–153. 2013.
|
|
35
|
Li D, He Q, Li R, Xu X, Chen B and Xie A:
Interleukin-10 promoter polymorphisms in Chinese patients with
Parkinson’s disease. Neurosci Lett. 513:183–186. 2012.
|
